Kreis, Kristine; Horenkamp-Sonntag, Dirk; Schneider, Udo; Zeidler, Jan; Glaeske, Gerd; Weissbach, Lothar
(Berlin : Springer, 2021)
Purpose: Treatments for patients with metastatic castration-resistant prostate cancer (mCRPC) have expanded rapidly. They include the chemotherapies docetaxel and cabazitaxel, hormonal drugs abiraterone and enzalutamide, ...